Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Oct 1;143(10):2868-2871.
doi: 10.1093/brain/awaa287.

Lowering the risk of Parkinson's disease with GLP-1 agonists and DPP4 inhibitors in type 2 diabetes

Ece Bayram  1 , Irene Litvan  1
Affiliations
Comment

Lowering the risk of Parkinson's disease with GLP-1 agonists and DPP4 inhibitors in type 2 diabetes

Ece Bayram et al. Brain. .

Abstract

This scientific commentary refers to ‘Diabetes medications and risk of Parkinson’s disease: a cohort study of patients with diabetes’, by Brauer etal. (doi:10.1093/brain/awaa262).

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic showing key results from Brauer etal. (2020). Findings suggest that increased Parkinson’s disease risk owing to type 2 diabetes mellitus may be modified by use of specific antidiabetic drugs.
See this image and copyright information in PMC

Comment on

References

    1. Athauda D, Maclagan K, Skene SS, Bajwa-Joseph M, Letchford D, Chowdhury K, et al.Exenatide once weekly versus placebo in Parkinson’s disease: a randomised, double-blind, placebo-controlled trial. Lancet 2017; 390: 1664–75. - PMC - PubMed
    1. Aviles-Olmos I, Dickson J, Kefalopoulou Z, Djamshidian A, Ell P, Soderlund T, et al.Exenatide and the treatment of patients with Parkinson’s disease. J Clin Invest 2013; 123: 2730–6. - PMC - PubMed
    1. Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, et al.MDS research criteria for prodromal Parkinson’s disease. Mov Disord 2015; 30: 1600–11. - PubMed
    1. Brauer R, Wei L, Ma TT, Athauda D, Girges C, Vijiaratnam, et al.Diabetes mediations and risk of Parkinson’s disease: a cohort study of diabetes patients. Brain 2020; 143: 3067–76. - PMC - PubMed
    1. Heinzel S, Berg D, Gasser T, Chen H, Yao C, Postuma RB.. Update of the MDS research criteria for prodromal Parkinson’s disease. Mov Disord 2019; 34: 1464–70. - PubMed

Publication types

MeSH terms